Benzinga | Jul 29, 2021 04:32PM EDT

Emergent BioSolutions Q2 EPS $0.33 Down From $1.98 YoY, Sales $397.50M Miss $398.93M Estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $0.33 per share. This is a 83.33 percent decrease over earnings of $1.98 per share from the same period last year. The company reported quarterly sales of $397.50 million which missed the analyst consensus estimate of $398.93 million by 0.36 percent. This is a 0.71 percent increase over sales of $394.70 million the same period last year.